AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Brockhaus Technologies AG

Earnings Release Sep 29, 2020

712_ip_2020-09-29_386cbaa4-9d29-4d57-a2d7-8a5e61f6c1e5.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

ELEVATING CHAMPIONS

Earnings Call - H1 2020 | 29 September 2020

Disclaimer

Important information for recipients

This document is being presented solely for informational purposes and should not be treated as giving investment advice. It is not intended to be (and should not be used as) the sole basis of any analysis or other evaluation. All and any evaluations or assessments stated herein represent our personal opinions. We advise you that some of the information is based on statements by third persons, and that no representation or warranty, expressed or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of this information or opinions contained herein.

This presentation contains certain forward-looking statements relating to the business, financial performance and results of Brockhaus Capital Management AG and its subsidiaries (collectively the "BCM Group") and/ or the industries in which BCM Group operates. Forward looking statements concern future circumstances and results and other statements that are not historical facts, sometimes identified by the words "believes", "expects", "predicts", "intends", "projects", "plans", "estimates", "aims", "foresees", "anticipates", "targets", and similar expressions. The forward-looking statements contained in this presentation, including assumptions, opinions and views of BCM-Group or cited from third party sources, are solely opinions and forecasts which are uncertain and subject to risks. Actual events may differ significantly from any anticipated development due to a number of factors, including without limitation, changes in general economic conditions, in particular economic conditions in the markets in which BCM Group operates, changes affecting interest rate levels, changes in competition levels, changes in laws and regulations, environmental damages, the potential impact of legal proceedings and actions and BCM Group's ability to achieve synergies from acquisitions. In general, the potential impact of COVID-19 on BCM's business is uncertain and will, among others, depend on the further development of the pandemic and other developments worldwide such as the (re-)implementation and duration of national and regional lock-down measures or the development of leading international economies in light of the pandemic. BCM Group does not guarantee that the assumptions underlying the forward-looking statements in this presentation are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or any obligation to update the statements in this presentation to reflect subsequent events. The forward-looking statements in this presentation are made only as of the date hereof. Neither the delivery of this presentation nor any further discussions of BCM Group with any of the recipients thereof shall, under any circumstances, create any implication that there has been no change in the affairs of BCM Group since such date. Consequently, BCM Group does not undertake any obligation to review, update or confirm recipients' expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of the presentation.

Neither Brockhaus Capital Management AG nor any other person shall assume any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any use of this presentation or the statements contained herein as to unverified third person statements, any statements of future expectations and other forward-looking statements, or the fairness, accuracy, completeness or correctness of statements contained herein, or otherwise arising in connection with this presentation.

Summary H1 2020

Group KPIs

  • Revenue growth of +1% (compared to pro forma H1 2019)
    • o Below long-term target growth due to COVID-19
    • o However significantly better than expected (guidance from 29 June: "high single digit percentage decline")
  • Gross profit at 73.7% of total output (slightly up 2.0%-points)
  • Adj. EBITDA margin 20.4% (down 8.7%-points)
    • o Negative cut-off date effects from change in finished goods and work in progress compared to H1 2019
    • o Already in 2019, structures were ramped-up for double digit top line growth
    • o Leveraging flexibility in operating cost base
    • o But avoiding measures that would endanger the Group's future growth prospects

Deal flow

  • Strong deal pipeline and due diligence activity in H1 despite COVID-19 pandemic and IPO preparations
    • o >2,200 companies actively screened and 195 opportunities introduced by M&A advisors and network
    • o 15 management presentations (both virtually and physically)
    • o Currently 3 companies in due diligence from the Healthcare, MedTech and Software spaces

Revenue 2020 by quarter

Revenue H1 2020 by region

KPIs by segment

Environmental
Technologies
Security
Technologies
Central
Functions
Total
€ thousand H1 2020 H1 2019 H1 2020 H1 2019 H1 2020 H1 2019 H1 2020 H1 2019
Revenue 5,956 5,717 17,203 17,296 - - 23,160 23,013
Revenue growth 4.2% (0.5%) 0.6%
Gross profit 4,676 4,749 12,469 12,935 - - 17,144 17,684
Gross margin 78.5% 83.1% 72.5% 74.8% 74.0% 76.8%
Adjusted EBITDA 1,605 2,055 5,300 5,945 (2,189) (1,294) 4,716 6,706
Adjusted EBITDA margin 26.9% 35.9% 30.8% 34.4% 20.4% 29.1%

Reportable segments

Palas

  • Test rigs for face masks successfully developed, launched and marketed
  • Patent filed for the measurement of virus-sized particles in exhaled air – product launch imminent
  • Successful market entry in Asia
    • o Hong Kong and Shanghai subsidiaries founded
    • o MD Asia with local sales team up and running
    • o First order intake

€ thousand H1 2020 H1 2019
Revenue 5,956 5,717
Revenue growth 4.2%
Gross profit 4,676 4,749
Gross margin 78.5% 83.1%
Adjusted EBITDA 1,605 2,055
Adjusted EBITDA margin 26.9% 35.9%

  • Statutory travel and contact restrictions as well as customers' internal "no-contact policies" hamper on-site work for KVM system installations which is crucial to put the systems into operation
    • o Consequently, delayed conversion of pipeline into order intake, especially for larger projects
    • o Cautious optimism observable on customer side, but uncertainties remain
  • Development of an IP module to remotely access KVM installations, while maintaining their systematic security
  • New security certifications ongoing:
    • o US: NIAP (National Information Assurance Partnership)
    • o International: Common Criteria for Information Technology Security Evaluation
    • o Germany: KRITIS (critical infrastructure in accordance with the Federal Offices for Civil Protection, Disaster Assistance and Information Security)
€ thousand H1 2020 H1 2019
Revenue 17,203 17,296
Revenue growth (0.5%)
Gross profit 12,469 12,935
Gross margin 72.5% 74.8%
Adjusted EBITDA 5,300 5,945
Adjusted EBITDA margin 30.8% 34.4%

Deal flow

M&A activities in 2020 YTD

>2.200 companies actively screened

...195 acquisition opportunities through M&A advisors and network

…15 management presentations

…3 companies currently in due diligence

Selected current transactions from our pipeline

Healthcare Software

  • EBITDA margin: ~ 30%
  • Proprietary

  • EBITDA margin: ~ 40%
  • M&A process

MedTech

  • EBITDA margin: ~ 20%
  • M&A process

EXCERPT ONLY

Guidance

Guidance FY2020

Please refer to the section "Expected developments" of the management report in our half-year financial report H1 2020 (page 36)

Q&A

Happy to answer your questions

Brockhaus Capital Management AG

NEXTOWER | Thurn-und-Taxis-Platz 6

D-60313 Frankfurt am Main

T: +49 (0) 69 20 43 40 90

F: +49 (0) 69 20 43 40 971

Mail: [email protected]

Trading symbol: BKHT ISIN: DE000A2GSU42

Talk to a Data Expert

Have a question? We'll get back to you promptly.